tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Michael Leuchten, 6 are a BUY (30%), 11 are a HOLD (55%), 3 are a SELL (15%).
Analyst Michael Leuchten works at UBS with a stock forecast success ratio of 50% fulfilled within 206.5 days on average.
Michael Leuchten’s has documented 35 price targets and ratings displayed on 6 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on AZN, AstraZeneca PLC ADR at 12-Jul-2023.
Analyst best performing recommendations are on NVO (NOVO NORDISK A/S).
The best stock recommendation documented was for NVO (NOVO NORDISK A/S) at 3/23/2020. The price target of $31.06 was fulfilled within 30 days with a profit of $7.06 (29.42%) receiving and performance score of 9.81.
Average potential price target upside
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
80
$12.3 (18.17%)
83
2 months 7 days ago
0/3 (0%)
$19.52 (32.28%)
Hold
2 months 11 days ago
0/11 (0%)
$82.61 (131.40%)
Buy
85
$17.3 (25.55%)
2 months 27 days ago
0/11 (0%)
$19.26 (29.30%)
Hold
70
$2.3 (3.40%)
3 months 16 days ago
4/5 (80%)
$2.71 (4.03%)
253
Buy
142.74
9 months 7 days ago
0/6 (0%)
$75.62 (112.66%)
What Year was the first public recommendation made by Michael Leuchten?
